Medtronic Minimally Invasive Therapies will launch its SolitaireFR revascularization device for acute ischemic strokes in the U.S. next month following receipt of 510(k) clearance, the firm announced March 5.
The FDA clearance comes several weeks earlier than expected. During the firm’s Jan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?